1. Lowder JL, Ghetti C, Nikolajski C, Oliphant SS, Zyczynski HM. Body image perceptions in women with pelvic organ prolapse: a qualitative study. <em>Am J Obstet Gynecol</em>. 2011;204(5):441. doi:10.1016/j.ajog.2010.12. 024
2. Sung VW, Washington B, Raker CA. Costs of ambulatory care related to female pelvic floor disorders in the United States. <em>Am J Obstet Gynecol</em>. 2010;202(5):483. doi:10.1016/j.ajog.2010.01.015
3. Oliphant SS, Jones KA, Wang L, Bunker CH, Lowder JL. Trends over time with commonly performed obstetric and gynecologic inpatient procedures. <em>Obstet Gynecol</em>. 2010;116(4):926-931. doi:10.1097/AOG. 0b013e3181f38599
4. Wu JM, Hundley AF, Fulton RG, Myers ER. Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. <em>Obstet Gynecol</em>. 2009;114(6):1278-1283. doi:10.1097/AOG.0b013e3181c2ce96
5. Raglan O, Kalliala I, Markozannes G, et al. Risk factors for endometrial cancer: an umbrella review of the literature. <em>Int J Cancer</em>. 2019;145(7): 1719-1730. doi:10.1002/ijc.31961
6. Accessed https://seer.cancer.gov/registries/data.html.
7. Ferris JS, Prest MT, Hur C, et al. Trends in uterine cancer incidence in the United States: The contribution of age, period and cohort effects. <em>Gynecol Oncol</em>. 2024;187:151-162. doi:10.1016/j.ygyno.2024.04.026
8. La Vecchia C. Ovarian cancer: epidemiology and risk factors. <em>Eur J Cancer Prev</em>. 2017;26(1):55-62. doi:10.1097/CEJ.0000000000000217
9. Nicholson RC, Khunda A, Ballard P, Rees J, McCormick C. Prevalence of histological abnormalities in hysterectomy specimens performed for prolapse. A systematic review and meta-analysis. <em>Int Urogynecol J</em>. 2021; 32(12):3131-3141. doi:10.1007/s00192-021-04858-z
10. Elbiaa AA, Abdelazim IA, Farghali MM, Hussain M, Omu AE. Unexpected premalignant gynecological lesions in women undergoing vaginal hysterectomy for utero-vaginal prolapse. <em>Prz Menopauzalny</em>. 2015;14(3):188-191. doi:10.5114/pm.2015.54344
11. Kaur H, Qadri S, Nevill AM, Ewies AAA. The optimal endometrial thickness threshold for prediction of endometrial cancer in postmenopausal women without bleeding remains uncertain-systematic review and meta-analysis. <em>J Gynecol Obstet Hum Reprod</em>. 2024;53(10):102831. doi:10.1016/j.jogoh.2024.102831
12. Wang JH, Zhao J, Lin J. Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies. <em>J Minim Invasive Gynecol</em>. 2010;17(1):53-58. doi:10.1016/j.jmig.2009.10.012
13. Gregoriou O, Konidaris S, Vrachnis N, et al. Clinical parameters linked with malignancy in endometrial polyps. <em>Climacteric</em>. 2009;12(5):454-458. doi:10.1080/13697130902912605
14. Baiocchi G, Manci N, Pazzaglia M, et al. Malignancy in endometrial polyps: a 12-year experience. <em>Am J Obstet Gynecol</em>. 2009;201(5):462. doi: 10.1016/j.ajog.2009.05.055
15. Antunes A, Jr., Costa-Paiva L, Arthuso M, Costa JV, Pinto-Neto AM. Endometrial polyps in pre-and postmenopausal women: factors associated with malignancy. <em>Maturitas</em>. 2007;57(4):415-421. doi:10.1016/ j.maturitas.2007.04.010